| Issue Date | Title | Author(s) |
| 2015-03-27 | ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype. | Junankar, S; Baker, LA; Roden, DL; Nair, R; Elsworth, B; Gallego-Ortega, D; Lacaze, P; Cazet, A; Nikolic, I; Teo, WS; Yang, J; McFarland, A; Harvey, K; Naylor, MJ; Lakhani, SR; Simpson, PT; Raghavendra, A; Saunus, J; Madore, J; Kaplan, W; Ormandy, C; Millar, EKA; O'Toole, S; Yun, K; Swarbrick, A |
| 2017-07 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. | Law, AMK; Lim, E; Ormandy, CJ; Gallego-Ortega, D |
| 2017-04-05 | Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. | Vennin, C; Chin, VT; Warren, SC; Lucas, MC; Herrmann, D; Magenau, A; Melenec, P; Walters, SN; Del Monte-Nieto, G; Conway, JRW; Nobis, M; Allam, AH; McCloy, RA; Currey, N; Pinese, M; Boulghourjian, A; Zaratzian, A; Adam, AAS; Heu, C; Nagrial, AM; Chou, A; Steinmann, A; Drury, A; Froio, D; Giry-Laterriere, M; Harris, NLE; Phan, T; Jain, R; Weninger, W; McGhee, EJ; Whan, R; Johns, AL; Samra, JS; Chantrill, L; Gill, AJ; Kohonen-Corish, M; Harvey, RP; Biankin, AV; Australian Pancreatic Cancer Genome Initiative (APGI),; Evans, TRJ; Anderson, KI; Grey, ST; Ormandy, CJ; Gallego-Ortega, D; Wang, Y; Samuel, MS; Sansom, OJ; Burgess, A; Cox, TR; Morton, JP; Pajic, M; Timpson, P |
| 2021-12 | Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization. | Mayer, JU; Hilligan, KL; Chandler, JS; Eccles, DA; Old, SI; Domingues, RG; Yang, J; Webb, GR; Munoz-Erazo, L; Hyde, EJ; Wakelin, KA; Tang, S-C; Chappell, SC; von Daake, S; Brombacher, F; Mackay, CR; Sher, A; Tussiwand, R; Connor, LM; Gallego-Ortega, D; Jankovic, D; Le Gros, G; Hepworth, MR; Lamiable, O; Ronchese, F |
| 2022-07 | ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. | Law, AMK; Chen, J; Colino-Sanguino, Y; Fuente, LRDL; Fang, G; Grimes, SM; Lu, H; Huang, RJ; Boyle, ST; Venhuizen, J; Castillo, L; Tavakoli, J; Skhinas, JN; Millar, EKA; Beretov, J; Rossello, FJ; Tipper, JL; Ormandy, CJ; Samuel, MS; Cox, TR; Martelotto, L; Jin, D; Valdes-Mora, F; Ji, HP; Gallego-Ortega, D |
| 2022-05-03 | Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. | Ho, W-HJ; Law, AMK; Masle-Farquhar, E; Castillo, LE; Mawson, A; O'Bryan, MK; Goodnow, CC; Gallego-Ortega, D; Oakes, SR; Ormandy, CJ |
| 2016-01-07 | ELF5 isoform expression is tissue-specific and significantly altered in cancer. | Piggin, CL; Roden, DL; Gallego-Ortega, D; Lee, HJ; Oakes, SR; Ormandy, CJ |
| 2017-04 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. | Law, AMK; Lim, E; Ormandy, CJ; Gallego-Ortega, D |
| 2020-05 | Capillary-assisted microfluidic biosensing platform captures single cell secretion dynamics in nanoliter compartments. | Hassanzadeh-Barforoushi, A; Warkiani, ME; Gallego-Ortega, D; Liu, G; Barber, T |
| 2018-11-30 | ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. | Pinho, AV; Van Bulck, M; Chantrill, L; Arshi, M; Sklyarova, T; Herrmann, D; Vennin, C; Gallego-Ortega, D; Mawson, A; Giry-Laterriere, M; Magenau, A; Leuckx, G; Baeyens, L; Gill, AJ; Phillips, P; Timpson, P; Biankin, AV; Wu, J; Rooman, I |
